Eli Lilly and Company

Overview

Eli Lilly and Company is a global pharmaceutical company known for its innovative contributions to the field of medicine. The company develops, manufactures, and markets pharmaceutical products across a wide range of therapeutic areas. It is committed to advancing medical research and improving patient outcomes.

Therapeutic areas

API / Drug Master Files

Eli Lilly and Company holds 0 active (39 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MDX-068 (HUMANIZED ANTI-B-AMYLOID MONOCLONAL ANTIBODY)Inactive2004-03-15
• DIPEPTIDYLAMINOPEPTIDASE (DDAP)Inactive2001-06-05
• CAPREOMYCIN SULFATE, STERILE BULK (CAPASAT)Inactive2001-02-27
• RECOMBINANT BOVINE TRYPSIN (RTRYPSIN)Inactive2000-09-18
• RECOMBINANT PORCINE CARBOXYPEPTIDASE B (RCPB)Inactive2000-09-18
• DIPEPTIDYLAMINOPEPTIDASE (DDAP)Inactive1998-12-08
• CYCLOSERINEInactive1998-09-01
• ERYTHROMYCIN ESTOLATEInactive1998-09-01
• CEFUROXIME SODIUMInactive1998-09-01
• VANCOMYCIN HYDROCHLORIDEInactive1998-09-01
• CEFACLORInactive1998-09-01
• CEFAMANDOLE SODIUMInactive1998-09-01
• CEFACLORInactive1998-09-01
• CEFAMANDOLE NAFATEInactive1998-09-01
• CEFAMANDOLE NAFATEInactive1998-09-01

Showing 15 of 39 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Eli Lilly and Company in our records. PharmaTek screens the full directory against live FDA enforcement data.